Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedOct 24, 2018CVS HealthCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0031-2019Class IITerminatedOct 24, 2018CVS HealthCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0030-2019Class IITerminatedOct 24, 2018CareOne, Saline Nasal Gel With Soothing AloeCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0029-2019Class IITerminatedOct 24, 2018RhinallCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0028-2019Class IITerminatedOct 24, 2018DERMATONEMicrobial Contamination of Non-Sterile Products: sample tested positive for Staphylococcus aureus.Product Quest Manufacturing LLC · D-0027-2019Class IIITerminatedOct 24, 2018Levonorgestrel and Ethinyl Estradiol TabletsLabeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.Mylan Pharmaceuticals Inc. · D-0025-2019Class IITerminatedOct 24, 2018Thyroid, USPCGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.Humco Holding Group, Inc · D-0024-2019Class IITerminatedOct 24, 2018Thyroid, USPCGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.Humco Holding Group, Inc · D-0023-2019Class IITerminatedOct 24, 2018Thyroid, USPCGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.Humco Holding Group, Inc · D-0022-2019Class IITerminatedOct 17, 2018Prevacid 24HRCGMP deviationsGlaxosmithkline Nebraska · D-0088-2019Class IITerminatedOct 17, 2018Actoplus met XRDefective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.Takeda Development Center Americas, Inc. · D-0026-2019Class IIITerminatedOct 17, 2018Altavera Levonorgestrel and Ethinyl Estradiol TabletsLabeling: Not Elsewhere Classified: mislabeling of the Altavera generic name on the packaging component that may cause confusion.Xiromed LLC · D-0016-2019Class IITerminatedOct 17, 2018Magnesium Sulfate in Water for InjectionCorrect Labeled Product Mispack: confirmed report involving a single unit of properly labeled Heparin in 0.45% Sodium Chloride for Injection (NDC 0409-7651-03, Lot...Pfizer Inc. · D-0015-2019Class IITerminatedOct 17, 2018THYROID POWDER USPCGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.Syntec Pharma Corp · D-0014-2019Class IITerminatedOct 17, 2018THYROID POWDER USPCGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.Syntec Pharma Corp · D-0013-2019Class IIITerminatedOct 17, 2018Amlodipine Besylate USP 10 mg TabletsSubpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.InvaGen Pharmaceuticals, Inc. · D-0012-2019Class IITerminatedOct 17, 2018Pantoprazole Sodium Delayed-Release TabletsDiscoloration: Presence of dark discoloration or brown spots on the edges of the tablets.Jubilant Cadista Pharmaceuticals, Inc. · D-0011-2019Class IITerminatedOct 17, 2018Glipizide XLCGMP Deviations; rejected product was used to manufacture final bulk lotPfizer Inc. · D-0010-2019Class IITerminatedOct 17, 2018Thyroid powderCGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.Alkano Chemicals, Inc · D-0008-2019Class IIITerminatedOct 10, 2018treatNOW ABILIFYLabeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and...Otsuka Pharmaceutical Development & Commercialization, Inc. · D-0018-2019Class IIITerminatedOct 10, 2018treatNOW ABILIFYLabeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and...Otsuka Pharmaceutical Development & Commercialization, Inc. · D-0017-2019Class ITerminatedOct 10, 2018robaxin-750Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct...Endo Pharmaceuticals, Inc. · D-0009-2019Class IITerminatedOct 10, 2018Nystatin and Triamcinolone Acetonide CreamFailed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.Dr. Reddy's Laboratories, Inc. · D-0007-2019Class IITerminatedOct 10, 2018Thyroid Powder 25kg/drumCGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.Sichuan Friendly Pharmaceutical Co.,Ltd. · D-0006-2019Class IITerminatedOct 10, 2018ElelysoLack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the...Pfizer Inc. · D-0005-2019Class IITerminatedOct 10, 2018NeoRelief for Muscle Cramping & Restlessness Homeopathic Topical GelCGMP Deviations: finished product produced with active ingredients recalled by the manufacturer, King Bio Inc., due to water contamination issues that could potentially...BioLyte Laboratories, LLC · D-0002-2019Class IITerminatedOct 10, 2018Clozapine Orally Disintegrating TabletsFailed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.Teva Pharmaceuticals USA · D-0001-2019Class IITerminatedOct 3, 2018SynjardyCross Contamination With Other Products:Boehringer Ingelheim Pharmaceuticals, Inc. · D-1217-2018Class IIITerminatedOct 3, 2018Levofloxacin Injection in 5% DextroseSuperpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.Baxter Healthcare Corporation · D-1215-2018Class IITerminatedOct 3, 2018Montelukast Sodium TabletsDiscoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.Hetero Labs Limited Unit V · D-1213-2018Class IIITerminatedOct 3, 2018Fenofibrate TabletsPresence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.Hetero Labs, Ltd. - Unit III · D-1211-2018Class IITerminatedOct 3, 2018MinivelleDefective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.Noven Pharmaceuticals, Inc. · D-1210-2018Class IITerminatedOct 3, 2018MinivelleDefective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.Noven Pharmaceuticals, Inc. · D-1209-2018Class IITerminatedOct 3, 2018MinivelleDefective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.Noven Pharmaceuticals, Inc. · D-1208-2018Class IITerminatedOct 3, 2018MinivelleDefective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.Noven Pharmaceuticals, Inc. · D-1207-2018Class IIITerminatedOct 3, 2018Zoledronic Acid InjectionFailed Impurities/Degradation Specifications: OOS for unknown impurities.Dr. Reddy's Laboratories, Inc. · D-0104-2019Class IIITerminatedOct 3, 2018Zoledronic Acid InjectionFailed Impurities/Degradation Specifications: OOS for unknown impurities.Dr. Reddy's Laboratories, Inc. · D-0103-2019Class IOngoingOct 3, 2018Montelukast Sodium Tablets 10 mgLabeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.Hetero Labs Limited Unit V · D-0081-2019Class IIITerminatedSep 26, 2018Morphine Sulfate Extended-Release TabletsFailed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone...Lupin Somerset · D-1214-2018Class IIITerminatedSep 26, 2018Bupropion Hydrochloride ER TabletsFailed impurities/ degradation specifications: Out-of-specification results were observed in the meta-chlorobenzoic acid impurity in batches 18 months or older from date...InvaGen Pharmaceuticals, Inc. · D-1212-2018

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.